EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic

Borek Sehnal iD, Martin Hruda iD, Radoslav Matej iD, Helena Robova iD, Jana Drozenova, Tomas Pichlik iD, Michael J Halaska iD, Lukas Rob iD, Pavel Dundr iD

Geburtshilfe und Frauenheilkunde · 01.04.2025 · 85 (04) · 405-416

DOI: 10.1055/a-2494-8395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.04.2025. Verfasst von Borek Sehnal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague 10, Czech…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: lékařská fakulta Univerzity Karlovy, Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The International Federation of Gynaecology and Obstetrics (FIGO) introduced a new staging system for endometrial carcinoma FIGO 2023 in June 2023. The new staging system differs significantly from previous versions by incorporating other non-anatomical parameters (histological type of tumour, tumour grade and the presence of massive lymphovascular space involvement as well as the molecular classification of the tumour). The FIGO 2023 staging system enhances the accuracy of prognostic assessments for patients at a specific stage with better options for targeted treatment. Another objective was to synchronise staging as much as possible with the European oncogynaecological ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma established in 2021. However, several changes are controversial. Routine molecular classification of endometrial carcinomas is not yet commonly available in most countries of the world. Another limitation of the FIGO 2023 staging system of endometrial cancer is the inclusion of variables whose definitions are still evolving, as well as variables that are subject to considerable interobserver variability in their assessment. Advantages, controversies, and limitations for clinical practice of the new FIGO 2023 endometrial cancer staging system are discussed.

Schlagwörter

Stichwörter der Autor:innen

ESGOESPESTROFIGO 2023controversiesendometrial cancermolecular classificationstagingstaging system

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague 10, Czech Republic.
  • Department of Pathology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague 10, Czech Republic.
  • Department of Pathology and Molecular Medicine, Thomayer University Hospital and Third Faculty of Medicine, Charles University, Prague 4, Czech Republic.
  • Department of Pathology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague 2, Czech Republic.

ORCID-Profile: Borek Sehnal, Martin Hruda, Radoslav Matej, Helena Robova, Tomas Pichlik, Michael J Halaska, Lukas Rob, Pavel Dundr

Förderung

  • lékařská fakulta Univerzity Karlovy
  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Sehnal, B., Hruda, M., Matej, R., Robova, H., Drozenova, J., Pichlik, T., Halaska, M. J., Rob, L., & Dundr, P. (2025). New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic. Geburtshilfe und Frauenheilkunde, 85(04), 405-416. https://doi.org/10.1055/a-2494-8395

Vancouver

Sehnal B, Hruda M, Matej R, Robova H, Drozenova J, Pichlik T, et al. New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic. Geburtshilfe und Frauenheilkunde. 2025;85(04):405-416. doi:10.1055/a-2494-8395

BibTeX
@article{Sehnal2025,
  author = {Sehnal, Borek and Hruda, Martin and Matej, Radoslav and Robova, Helena and Drozenova, Jana and Pichlik, Tomas and Halaska, Michael J and Rob, Lukas and Dundr, Pavel},
  title = {New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic},
  journal = {Geburtshilfe und Frauenheilkunde},
  year = {2025},
  volume = {85},
  number = {04},
  pages = {405--416},
  doi = {10.1055/a-2494-8395}
}
Kostenlos starten →